Inclusion criteria | Exclusion criteria |
---|---|
Participant in PRESENT cohort | Lesion in C1, and C2 |
Filling out PRESENT-questionnaires | Contraindication for MRI if MRI is indicated |
Broad consent for randomization to experimental interventions | Radiosensitive histology such as multiple myeloma |
Histologic proof of malignancy | Unable to undergo SBRT treatment |
Imaging evidence of bone metastases | Patient with < 3 months life expectancy |
For spinal lesions, per lesion no more than 3 consecutive spine segments involved with one unaffected vertebral body above and below | Chemotherapy or systemic radionuclide delivery within 24Â h before and after SBRT |
No more than 2 painful lesions needing treatment | Previous EBRT or SBRT to same level |
For spinal lesions, no compression of spinal cord | For spinal lesions, unstable spine requiring surgical stabilization |
No or mild neurological signsa | Severe, worsening or progressive neurological deficit |
KPS > 50 and pain score > 3b |  |